<ѻý>Families Push Research Forward in Rare Diseasesѻý> The field has a unique funding model. While fruitful, some question if it needs to change. Dec 26, 2022
<ѻý>FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancerѻý> Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
<ѻý>'Constant Turmoil' at FDA Makes Our Food Less Safeѻý> Reflections on a new report about the agency's Human Foods Program Dec 16, 2022
<ѻý>'Tony Was Always a Very Clear Voice': Colleagues Bid Fond Farewell to Fauciѻý> Infectious disease, public health colleagues praise his knowledge, bedside manner, and leadership Dec 16, 2022
<ѻý>Funding, Policy Changes Needed to End Maternal Health Crisis, Federal Officials Sayѻý> Congress urged to take action Dec 14, 2022
<ѻý>'Whole-of-Government' Approach Needed for Diet-Related Illnesses, Senator Saysѻý> "Food as medicine" programs can lower blood sugar, reduce hospitalizations, experts note Dec 13, 2022
<ѻý>Physical and Occupational Therapy Are on the Medicare Chopping Blockѻý> Cuts could be devastating to patient care if Congress doesn't take action Dec 12, 2022
<ѻý>Why Does Makena Remain on the Market?ѻý> Misguided equity claims do not resolve issues with the accelerated approval program Dec 11, 2022
<ѻý>Medicare Must Pay Docs More, Say MedPAC Commissionersѻý> Two proposals discussed at the commission's December meeting would increase physician pay Dec 09, 2022
<ѻý>Should Doctors Warn Patients About the Downsides of Medicare Advantage Plans?ѻý> Beneficiaries may not be aware of the plans' limited networks or prior authorization rules Dec 08, 2022
<ѻý>'Our Culture War Is Killing People,' Says Former NIH Directorѻý> Francis Collins talks Elon Musk, vaccine misinformation, and long COVID Dec 07, 2022
<ѻý>Where Did All the Monkeypox Go?ѻý> Mpox questions answered by Demetre "Doctor D" Daskalakis Dec 05, 2022
<ѻý>Looming Physician Pay Cut 'Unprecedented' and 'Unconscionable,' AMA President Saysѻý> Number of doctors who take Medicare patients could dwindle without Congressional action Dec 02, 2022
<ѻý>New IDH1 Inhibitor Wins FDA Approval for Acute Myeloid Leukemiaѻý> Olutasidenib led to a 35% response rate in a study of adults with previously treated AML Dec 02, 2022
<ѻý>Stop Passing Off Politics as Evidenced-Based Medicineѻý> Scientific results cannot be understood through a framework of rigid political doctrine Dec 01, 2022
<ѻý>FDA Greenlights First Fecal Microbiota Productѻý> Rebyota approved for preventing recurrence of C. difficile infection Dec 01, 2022
<ѻý>As He Steps Down, Fauci Urges Everyone to Get Flu, COVID Vaccinesѻý> Asked about his legacy, he says he's "never left anything on the field" Nov 22, 2022
<ѻý>Watch for Severe Hypocalcemia in Dialysis Patients on Prolia, FDA Warnsѻý> Agency said potential risk may require more frequent blood calcium monitoring Nov 22, 2022
<ѻý>CDC's Updated Opioid Guidelines Are Necessary, but Not Sufficientѻý> Additional steps are needed to calibrate opioid access and undo harm Nov 18, 2022
<ѻý>FDA Approves First Drug to Delay Onset of Type 1 Diabetesѻý> Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
<ѻý>FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Controlѻý> Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
<ѻý>AMA Edges Closer to Supporting Public Optionѻý> Members will also oppose employer mandates requiring docs to sign contracts waiving due process Nov 16, 2022
<ѻý>After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Expertsѻý> Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
<ѻý>FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancerѻý> Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
<ѻý>Results Mixed for Docs Running for Congressѻý> Incumbents did better than challengers; some races still up in the air Nov 14, 2022
<ѻý>Expanding Vaccination Pay, 'Public Option' Fuel Debate Among AMA Delegatesѻý> Resolutions also advocate for greater accuracy in Medicare Advantage plan offerings and more Nov 14, 2022
<ѻý>Another Adalimumab Biosimilar Seems Set for Interchangeabilityѻý> Trial data pave way for FDA approval Nov 14, 2022
<ѻý>AMA President Says 'Enough is Enough' to Divisive Politics, Fake News in Medicineѻý> "We cannot allow physicians or our patients to become pawns," says Jack Resneck Jr., MD Nov 13, 2022
<ѻý>A Remedy for the Federally Funded Physician Shortageѻý> Raising or eliminating the cap on residency spots can make all the difference Nov 13, 2022
<ѻý>FDA Authorizes IL-1 Drug for Hospitalized COVID Patientsѻý> Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure Nov 09, 2022
<ѻý>Internal Strife at America's Frontline Doctors: Simone Gold Accused of Misusing $$$ѻý> Nasty fight now a federal lawsuit; Gold tries to regain company control Nov 07, 2022
<ѻý>COVID Spread Through Floors, Walls; Infant Pillow Warning; Paul Pelosi Dischargedѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 04, 2022
<ѻý>The USPSTF Process Is in Jeopardyѻý> A recent U.S. District Court ruling challenges the legitimacy of all task force recommendations Nov 02, 2022
<ѻý>Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Saysѻý> Warnings to patients and providers, improved accuracy needed, advisors say Nov 02, 2022
<ѻý>Regulators Move Against Two 'Misinformation' Doctorsѻý> Peter McCullough, MD, and Sherri Tenpenny, DO, face new scrutiny Nov 01, 2022
<ѻý>'Pill Mill' Docs, You May Be in for a Big Scareѻý> Two recent Supreme Court cases have major implications for physician practice Oct 27, 2022
<ѻý>The Updated COVID Boosters Could Have Been Betterѻý> From design to implementation, our bivalent shots missed the mark Oct 26, 2022
<ѻý>FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamabѻý> Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
<ѻý>Makena Is Just the Latest in Accelerated Approval Mayhemѻý> Congress must take action to reform the process Oct 24, 2022
<ѻý>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻý> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022